The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.
- Published In:
- Oncotarget, 6(33), 34910-23 (2015)
- Authors:
- Eike, Liv-Marie, Yang, Nannan, Rekdal, Øystein(4), Sveinbjørnsson, Baldur
- Database ID:
- RPEP-02619
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02619APA
Eike, Liv-Marie; Yang, Nannan; Rekdal, Øystein; Sveinbjørnsson, Baldur. (2015). The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.. Oncotarget, 6(33), 34910-23. https://doi.org/10.18632/oncotarget.5308
MLA
Eike, Liv-Marie, et al. "The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.." Oncotarget, 2015. https://doi.org/10.18632/oncotarget.5308
RethinkPeptides
RethinkPeptides Research Database. "The oncolytic peptide LTX-315 induces cell death and DAMP re..." RPEP-02619. Retrieved from https://rethinkpeptides.com/research/eike-2015-the-oncolytic-peptide-ltx315
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.